EXEL
Exelixis Inc
Price:  
55.68 
USD
Volume:  
2,031,013.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL Relative Valuation

22.4%
Upside

As of 2026-07-17, the Relative Valuation of Exelixis Inc (EXEL) is 68.14 USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.68 USD, the upside of Exelixis Inc based on Relative Valuation is 22.4%.

The range of the Relative Valuation is 56.76 - 80.37 USD.

Range Selected
Trailing P/E multiples 17.1x - 24.2x 18.4x
Forward P/E multiples 21.0x - 24.5x 23.5x
Fair Price 56.76 - 80.37 68.14
Upside 1.9% - 44.3% 22.4%
55.68 USD
Stock Price
68.14 USD
Fair Price

EXEL Relative Valuation - Historical P/E Data

Date P/E
2026-07-16 16.79
2026-07-15 16.75
2026-07-14 16.82
2026-07-13 16.90
2026-07-10 17.04
2026-07-09 17.22
2026-07-08 16.92
2026-07-07 17.22
2026-07-06 16.75
2026-07-02 16.84
2026-07-01 16.27
2026-06-30 16.41
2026-06-29 16.37
2026-06-26 16.52
2026-06-25 16.05
2026-06-24 15.95
2026-06-23 15.48
2026-06-22 15.49
2026-06-18 15.66
2026-06-17 15.82
2026-06-16 15.71
2026-06-15 15.98
2026-06-12 16.02
2026-06-11 16.14
2026-06-10 15.86
2026-06-09 15.98
2026-06-08 15.60
2026-06-05 15.89
2026-06-04 15.83
2026-06-03 15.56
2026-06-02 14.64
2026-06-01 15.16
2026-05-29 15.22
2026-05-28 15.52
2026-05-27 15.09
2026-05-26 15.07
2026-05-22 15.13
2026-05-21 14.97
2026-05-20 15.05
2026-05-19 14.68
2026-05-18 15.03
2026-05-15 15.12
2026-05-14 15.41
2026-05-13 15.47
2026-05-12 14.92
2026-05-11 14.99
2026-05-08 14.53
2026-05-07 13.94
2026-05-06 14.69
2026-05-05 13.40